Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative S-1/CDDP in Advanced Gastric Cancer
NCT00088816Phase 2Unknown
- Sponsor
- Kyoto University
- Start
- Apr 2003
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur-gimeracil-oteracil in gastric cancer (GC), sponsored by Kyoto University. Primary endpoints: Efficacy and feasibility of neoadjuvant chemotherapy and Overall Survival. Status: unknown.
02
Drugs
tegafur-gimeracil-oteracil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00088816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088816.